title: Adverse cardiac events during catecholamine therapy: a role for hydrocortisone?
authors.forename: A
authors.initials: A
authors.lastname: Salvadori
authors.forename: P
authors.initials: P
authors.lastname: Pasquier
authors.forename: A
authors.initials: A
authors.lastname: Jarrassier
authors.forename: J
authors.initials: J
authors.lastname: Renner
authors.forename: S
authors.initials: S
authors.lastname: Merat
mesh_terms: D002395:Catecholamines / Q000009:adverse effects* / Q000494:pharmacology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000139:chemically induced*; D013610:Tachycardia / Q000139:chemically induced*; D014662:Vasoconstrictor Agents / Q000009:adverse effects* / Q000494:pharmacology*
chemical_list: D002395:Catecholamines; D014662:Vasoconstrictor Agents